Data for: SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type
Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) is emerging as a key player in T-cell development, function and cancer. Here we investigated the role of GAPDH in T-cell development/function by overex
BackgroundT cell lymphomas (TCL) are a group of heterogeneous diseases with over 40 subtypes. In this study, we identified a novel TCL subtype which was featured by a unique T cell receptor (TCR) pres
This data set contains the supplementary methods, supplementary figures (7), and supplementary tables (7), for our manuscript titled "Skin microbiota differs between Black and White patients with cuta
Peripheral T-cell lymphomas (PTCL) are aggressive diseases with poor response to chemotherapy and dismal survival. Identification of effective strategies to target PTCL biology represents an urgent ne
T-cell lymphoma (TCL) is a collection of aggressive disorders with unfavorable outcome, where the introduction of targeted treatment is still in a preliminary phase. To gain deeper insights into dereg
